[HERZLIYA, Israel, Nov. 8, 2023] – One of the subsidiaries of Corundum Innovation Co. Ltd., Corundum Neuroscience, formerly Joy Ventures, announced the launch of its new neuroscience-focused venture builder and fund to spur neuroscience research and innovation.
The newly rebranded Corundum Neuroscience works with researchers and entrepreneurs with commercially applicable ideas to build and grow companies developing innovative solutions spanning a range of health and disease areas, including anxiety, depression, PTSD, chronic pain, sleep and neurodegenerative disorders.
Furthermore, Corundum Neuroscience will enhance collaboration with Corundum Systems Biology, another Corundum group company specialized in cutting edge gut-microbiome field, to advance both research and investment activities taking into consideration the contribution to gut-brain axis. Stay tuned for updates.
Learn more by visiting here.
About Corundum Innovation
Corundum Innovation Co., Ltd., and Corundum Ventures Ltd. (Hereafter Corundum) provide venture capital (VC) investment and consulting services to investors for both financial and strategic returns. Corundum provides flexible services to COIF’s investors for new business development in various phases with our expertise in science, technology, business development, corporate management, finance and consulting, as well as our strong network with top Israeli VC and the valuable information we can access through fund activities. Corundum’s support includes information gathering, negotiation for partnership, direct investment, market development, HR development, and fund formation.
Corundum Innovation Co., Ltd.